Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
23 Gennaio 2007 - 1:00PM
Business Wire
Akorn, Inc. (AMEX: AKN) today announced the positive results of a
Phase III pivotal trial for Akten�. The clinical trial was a
randomized, placebo controlled, multi-centered, 4-arm trial in 209
subjects. The primary efficacy end point for achieving ocular
anesthesia (p
Grafico Azioni Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (Borsa Americana (AMEX)): 0 articoli recenti
Più Akorn, Inc. Articoli Notizie